Track the 펩트론 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 펩트론 has published 31 insider filings. Market capitalisation: €3,860.7bn. The latest transaction was filed on 14 July 2026 (Other). Among the most active insiders: 최호일. All data is openly available.
31
Insider Decl.
n/a
Thresholds
n/a
11 ops.
Buy Volume
n/a
8 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Peptron is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative therapies and pharmaceutical products.